B. Ugarkar

发表

Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.

S. Cole, Anirban Ghosh, M. Fellows, 2015, Bioorganic & medicinal chemistry.

Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents.

B. Paul, B. Ugarkar, Balachandra S Bandodkar, 2012, ACS medicinal chemistry letters.

Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.

M. Erion, D. Dumas, A. Foster, 1999, The Journal of pharmacology and experimental therapeutics.

Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor.

R. K. Robins, G. R. Revankar, B. Ugarkar, 1986, Journal of medicinal chemistry.

Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.

M. Erion, A. Castellino, B. Ugarkar, 2000, Journal of medicinal chemistry.

Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.

M. Erion, P. D. van Poelje, K. R. Reddy, 2004, Journal of the American Chemical Society.

A New Synthesis of 2′,3′-Dideoxyinosine

B. Ugarkar, V. Bhat, E. Stocker, 1992 .

A Simple and Convenient Method for the Selective N-Acylations of Cytosine Nucleosides

V. Sayeed, B. Ugarkar, K. Grimm, 1989 .

Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.

M. Erion, Rohan V Mendonca, B. Ugarkar, 2005, Journal of Medicinal Chemistry.

Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.

B. Ugarkar, Michael C. Matelich, B. C. Bookser, 2005, Journal of medicinal chemistry.

Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.

M. Erion, A. Castellino, M. Ramirez-Weinhouse, 2003, Journal of medicinal chemistry.

Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.

M. Erion, A. Castellino, B. Ugarkar, 2000, Journal of medicinal chemistry.

Stereoselective synthesis of 4-C-methyl-2,3,5-tri-O-benzyl-d-ribofuranose and 4-C-methyl-2,3,5-tri-O-benzyl-l-lyxofuranose

M. Erion, B. Ugarkar, S. Boyer, 2003 .

Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.

M. Erion, P. D. van Poelje, K. R. Reddy, 2008, Journal of medicinal chemistry.

Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.

S. Prasad, J. Tucker, A. Gill, 2015, Journal of medicinal chemistry.

A Convenient Synthesis of 5-substituted 2-amino-1,3,4-oxadiazoles from Corresponding Acylthiosemicarbazides Using iodine and Oxone®

B. Ugarkar, V. Shinde, S. Ghorpade, 2013 .

A simple oxidation of formycin to oxoformycin and oxoformycin B. Synthesis of 6-methyloxoformycin, A C-nucleoside analog of doridosine

R. K. Robins, G. R. Revankar, B. Ugarkar, 1984 .

Sulphonamide and Sulphonate Derivatives of Sydnones

B. Ugarkar, B. V. Badami, G. Puranik, 1979 .

Short and Efficient Synthesis of Oxazinone- and Thiazinone-Containing Bicyclic Heteroaromatic Aldehydes

B. Ugarkar, V. Shinde, S. Hameed P, 2013 .

Improved Synthesis of Lycoricidine Triacetate

B. Ugarkar, E. Schubert, J. DaRe, 1987 .

Synthesis of 5-chloroformycin A, 5-chloro-2'-deoxyformycin A and certain related 5,7-disubstituted 3-beta-D-ribofuranosylpyrazolo[4,3-d] pyrimidines from formycin A.

R. K. Robins, G. R. Revankar, B. Ugarkar, 1986, Nucleic acids research.

Synthesis and antiviral/antitumor activities of certain pyrazolo[3,4-d]pyrimidine-4(5H)-selone nucleosides and related compounds.

R. K. Robins, G. R. Revankar, H. Cottam, 1984, Journal of medicinal chemistry.

Synthesis of 1-methyl-3-β-d-ribofuranosylpyrazolo[4, 3,-D]-pyrimidin-7(6h)-selone and Certain Related Nucleosides and Nucleotides

R. K. Robins, G. R. Revankar, B. Ugarkar, 1984 .

Design, Synthesis and Anticonvulsant Activity of the Potent Adenosine Kinase Inhibitor GP3269

M. Erion, A. Castellino, B. Ugarkar, 1997 .

Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity

M. Fellows, J. Neres, V. Ramachandran, 2016, ChemMedChem.

Modern Drug Discovery and Development for TB: The India Narrative

T. Balganesh, B. Ugarkar, J. Bhat, 2021 .

Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-β-d-arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma

M. Erion, D. Mackenna, K. R. Reddy, 2006 .

Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.

M. Erion, M. Allan, B. Ugarkar, 2005, Journal of medicinal chemistry.

A Convenient Synthesis of 5-substituted 2-amino-1,3,4-oxadiazoles from Corresponding Acylthiosemicarbazides Using iodine and Oxone®

B. Ugarkar, V. Shinde, S. Ghorpade, 2013 .